IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag
Author(s) -
Yadvinder S. Ahi,
Diborah Yimer,
Guoli Shi,
Saliha Majdoul,
Kazi Rahman,
Alan Rein,
Alex A. Compton
Publication year - 2020
Publication title -
mbio
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.562
H-Index - 121
eISSN - 2161-2129
pISSN - 2150-7511
DOI - 10.1128/mbio.03088-19
Subject(s) - infectivity , vesicular stomatitis virus , glycoprotein , retrovirus , murine leukemia virus , virology , viral envelope , virus , transmembrane protein , biology , microbiology and biotechnology , gammaretrovirus , in vitro , chemistry , biochemistry , receptor
The viral envelope glycoprotein, known as “Env” inRetroviridae , is found on the virion surface and facilitates virus entry into cells by mediating cell attachment and fusion. Env is a major structural component of retroviruses and is targeted by all arms of the immune response, including adaptive and innate immunity. Less is known about how cell-intrinsic immunity prevents retrovirus replication at the level of individual cells. Here, we show that cellular IFITM3 and IFITM2 inhibit the fusion potential of retroviral virions by inhibiting Env protein via a two-pronged mechanism. IFITM proteins inhibit Env abundance in cells and also impair its function when levels are low. The posttranslational block of retroviral Env function by IFITM proteins is likely to impede both exogenous and endogenous retrovirus replication. In support of a relevant role for IFITM3 in retrovirus control, the retroviral accessory protein glycoGag counteracts IFITM3 function to promote virus infectivity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom